Literature DB >> 21933186

Acquisition of neuron-like electrophysiological properties in neuroblastoma cells by controlled expression of NDM29 ncRNA.

Paola Gavazzo1, Serena Vella, Carla Marchetti, Mario Nizzari, Ranieri Cancedda, Aldo Pagano.   

Abstract

Neuroblastoma is a pediatric cancer characterized by high malignancy and remarkable cell heterogeneity within the tumor nodules. It has been previously shown that the over-expression of a specific non-coding RNA, NDM29, reduces neuroblastoma development promoting cell differentiation. We have used neuroblastoma cells expressing NDM29 at its basal level (Mock cells) or at 5.4-fold higher levels (S1 cells) to investigate whether a functional differentiation correlates with morphological and biochemical development induced by NDM29 expression. First, analyzing the expression of specific markers we demonstrated that NDM29 expression is accompanied by a well coordinated differentiation process toward a neuron-like, rather than toward a glial-like, phenotype. Next, we defined the neuron-like traits of S1 in terms of secretion of cytokines involved in axon guidance, synapse formation and neurite outgrowth. Finally, we characterized the ionic channel apparatus of S1 cells by patch-clamp technique and compared with the Mock counterpart. S1 cells showed much higher levels of fast inactivating Na(+) current and were able to generate mature action potentials. Moreover, they developed expression of functional GABA(A) receptors on their membrane. In contrast, the two cell lines shared very similar pools of functional K(+) channels, although slight quantitative differences can be described. Our results suggest that a maturation occurs in neuroblastoma as a consequence of NDM29 expression, inducing the appearance of neuronal-like properties. In this context, S1 cells may represent a novel in vitro tool for electrophysiological and pharmacological studies of human cells of the neural lineage.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21933186     DOI: 10.1111/j.1471-4159.2011.07492.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  Down-regulation of 21A Alu RNA as a tool to boost proliferation maintaining the tissue regeneration potential of progenitor cells.

Authors:  Arianna Gigoni; Delfina Costa; Massimiliano Gaetani; Roberta Tasso; Federico Villa; Tullio Florio; Aldo Pagano
Journal:  Cell Cycle       Date:  2016-08-05       Impact factor: 4.534

2.  Generation of a Functional Human Neural Network by NDM29 Overexpression in Neuroblastoma Cancer Cells.

Authors:  Susanna Alloisio; Patrizia Garbati; Federica Viti; Silvia Dante; Raffaella Barbieri; Giovanni Arnaldi; Alessia Petrelli; Arianna Gigoni; Paolo Giannoni; Rodolfo Quarto; Mario Nobile; Massimo Vassalli; Aldo Pagano
Journal:  Mol Neurobiol       Date:  2016-10-03       Impact factor: 5.590

3.  Perhexiline maleate enhances antitumor efficacy of cisplatin in neuroblastoma by inducing over-expression of NDM29 ncRNA.

Authors:  Serena Vella; Ilaria Penna; Luca Longo; Giulia Pioggia; Patrizia Garbati; Tullio Florio; Fabio Rossi; Aldo Pagano
Journal:  Sci Rep       Date:  2015-12-17       Impact factor: 4.379

Review 4.  Insights into lncRNAs in Alzheimer's disease mechanisms.

Authors:  Dingfeng Li; Juan Zhang; Xiaohui Li; Yuhua Chen; Feng Yu; Qiang Liu
Journal:  RNA Biol       Date:  2020-07-14       Impact factor: 4.652

5.  An intronic ncRNA-dependent regulation of SORL1 expression affecting Aβ formation is upregulated in post-mortem Alzheimer's disease brain samples.

Authors:  Eleonora Ciarlo; Sara Massone; Ilaria Penna; Mario Nizzari; Arianna Gigoni; Giorgio Dieci; Claudio Russo; Tullio Florio; Ranieri Cancedda; Aldo Pagano
Journal:  Dis Model Mech       Date:  2012-09-20       Impact factor: 5.758

6.  Efficacy of a Three Drug-Based Therapy for Neuroblastoma in Mice.

Authors:  Patrizia Garbati; Raffaella Barbieri; Matilde Calderoni; Francesca Baldini; Mario Nizzari; Paola Modesto; Tullio Florio; Aldo Pagano
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

7.  A novel collection of snRNA-like promoters with tissue-specific transcription properties.

Authors:  Sonia Garritano; Arianna Gigoni; Delfina Costa; Paolo Malatesta; Tullio Florio; Ranieri Cancedda; Aldo Pagano
Journal:  Int J Mol Sci       Date:  2012-09-11       Impact factor: 6.208

8.  Role of Btg2 in the progression of a PDGF-induced oligodendroglioma model.

Authors:  Irene Appolloni; Sebastiano Curreli; Sara Caviglia; Manuela Barilari; Eleonora Gambini; Aldo Pagano; Paolo Malatesta
Journal:  Int J Mol Sci       Date:  2012-11-12       Impact factor: 5.923

9.  The Murine PSE/TATA-dependent transcriptome: evidence of functional homologies with its human counterpart.

Authors:  Maria Jessica Bruzzone; Paola Gavazzo; Sara Massone; Carolina Balbi; Federico Villa; Anastasia Conti; Giorgio Dieci; Ranieri Cancedda; Aldo Pagano
Journal:  Int J Mol Sci       Date:  2012-11-13       Impact factor: 5.923

Review 10.  Novel ncRNAs transcribed by Pol III and elucidation of their functional relevance by biophysical approaches.

Authors:  Paola Gavazzo; Massimo Vassalli; Delfina Costa; Aldo Pagano
Journal:  Front Cell Neurosci       Date:  2013-11-07       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.